A study in Portugal revealed that 1/3 of sexually active girls aged 15-19 use the morning-after pill, while 16% use no birth control.
Despite receiving contraceptive information in school, risks remain high for young women.
In Peru, controversy surrounds the morning-after pill, with legislators debating its classification.
Concerns arise over easy access to emergency contraception, with some fearing it may deter regular gynecological visits.
The FDA's decision on nonprescription sales of emergency contraception remains contentious, highlighting ongoing debates on teen pregnancies and access to reproductive healthcare.
Ultimately, the focus should be on supporting women's choices and providing comprehensive reproductive health education
